Yaben Chemical resumes trading with limit down_ Securities Times Network

Securities Times e company news, Yaben Chemical resumed trading with a limit of more than 530,000 orders. Yaben Chemical announced on the evening of February 6 that during the suspension period, the company conducted a check on matters related to abnormal fluctuations in stock trading. In view of the completion of the relevant self-examination work, the company’s shares resumed trading. The company’s response to the letter of concern disclosed on January 5, 2022 stated that “Caron anhydride and its derivative products can be used to synthesize Pfizer’s new crown oral drug Palo Verde”, in which caron anhydride and its derivative products refer to It is a compound, not a product produced by the company. It cannot be determined that the caron anhydride and its derivative products produced by the company can be used to synthesize Pfizer’s new crown oral drug. The company has no business contact and cooperation with Pfizer, has not signed a cooperation agreement with Pfizer, and has not supplied caron anhydride products to Pfizer.